Calton & Associates, Inc. Kamada LTD Transaction History

Calton & Associates, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$4.14 - $6.22 $75,033 - $112,731	18,124 New	18,124 $110,000
Q2 2023 Jul 24, 2023	SELL	$4.48 - $5.53 $14,188 - $17,513	-3,167 Reduced 13.89%	19,630 $103,000
Q1 2023 Apr 19, 2023	SELL	$4.12 - $5.25 $6,006 - $7,654	-1,458 Reduced 6.01%	22,797 $105,000
Q4 2022 Jan 18, 2023	BUY	$3.79 - $4.84 $25,074 - $32,021	6,616 Added 37.51%	24,255 $0
Q3 2022 Oct 31, 2022	BUY	$4.42 - $5.43 $4,194 - $5,153	949 Added 5.69%	17,639 $79,000
Q2 2022 Jul 12, 2022	SELL	$4.22 - $5.85 $1,974 - $2,737	-468 Reduced 2.73%	16,690 $75,000
Q1 2022 Apr 12, 2022	SELL	$5.43 - $6.81 $8,992 - $11,277	-1,656 Reduced 8.8%	17,158 $94,000
Q4 2021 Jan 13, 2022	SELL	$5.21 - $6.82 $2,084 - $2,728	-400 Reduced 2.08%	18,814 $123,000
Q3 2021 Nov 05, 2021	SELL	$5.25 - $5.87 $819 - $915	-156 Reduced 0.81%	19,214 $101,000
Q2 2021 Aug 11, 2021	BUY	$5.67 - $6.33 $1,247 - $1,392	220 Added 1.15%	19,370 $113,000
Q1 2021 May 03, 2021	BUY	$6.02 - $8.06 $41,483 - $55,541	6,891 Added 56.21%	19,150 $119,000
Q4 2020 Jan 25, 2021	SELL	$6.3 - $8.46 $4,473 - $6,006	-710 Reduced 5.47%	12,259 $79,000
Q3 2020 Oct 30, 2020	SELL	$8.02 - $11.73 $5,862 - $8,574	-731 Reduced 5.34%	12,969 $108,000
Q2 2020 Aug 10, 2020	BUY	$5.37 - $9.45 $73,569 - $129,464	13,700 New	13,700 $106,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.